|
시장보고서
상품코드
2052789
뇌실외배액 시장 : 용도별, 환자 유형별, 최종사용자별, 지역별Global External Ventricular Drain Market, By Application, By Patient Type, By End User, By Geography |
||||||
세계의 뇌실외배액 시장은 2026년에 73억 1,000만 달러로 추정되며, 2033년까지 110억 달러에 달할 것으로 예상됩니다. 2026년부터 2033년까지 CAGR 6.0%로 성장할 것으로 전망됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도: | 2025년 | 2026년 시장 규모: | 73억 1,000만 달러 |
| 과거 데이터 기간: | 2020-2024년 | 예측 기간: | 2026-2033년 |
| 2026년부터 2033년까지 예측 기간 CAGR: | 6.00% | 2033년 시장 규모 예측: | 110억 달러 |
뇌실외배액(EVD)은 바홀(천공)을 통해 측뇌실 전각에 삽입되는 부드러운 카테터로, 폐쇄형 무균 시스템에 연결되어 뇌척수액(CSF)의 일시적 배출과 두개내압을 모니터링할 수 있는 카테터입니다. 뇌실외배액의 적응증은 상승된 두개 내압 감소, 감염된 뇌척수액(CSF) 배출, 뇌수술 및 출혈 후 혈액이 섞인 뇌척수액(CSF) 배출, 뇌척수액(CSF) 흐름의 우회, 두개 내압 모니터링입니다. 외부 배액 및 모니터링은 뇌척수액(CSF)을 체외로 배출하여 두개 내압을 일시적으로 조절하는 표준 치료법입니다. 외부 배액 및 모니터링은 뇌의 측뇌실 또는 척추의 요추강에서 뇌척수액(CSF)을 외부 수집 백으로 일시적으로 배출하는 시술입니다. 뇌실외배액(EVD) 시스템은 중력과 뇌내압의 조합을 이용하여 CSF를 배출합니다. 배출량은 환자의 해부학적 구조에 대한 EVD 시스템의 설치 높이에 따라 달라집니다.
시장 역학:
연구 개발(R&D) 활동의 증가는 예측 기간 동안 세계 뇌실외배액 시장의 성장을 견인할 것으로 예상됩니다. 예를 들어, 2025년 6월 스웨덴 카롤린스카 대학병원은 '뇌실외배액 관련 감염을 확인하기 위한 새로운 진단법'이라는 제목으로 임상시험을 시작했습니다. 이 조사에서는 뇌척수액(CSF) 내 세균을 신속하고 직접적으로 검출할 수 있는 세 가지 새로운 진단법을 평가하고, 이를 CSF 세균 배양과 비교하여 신경집중치료 환자의 항생제 치료 지침으로 활용할 수 있는지 검증합니다. 이 조사는 2026년 12월 31일까지 완료될 예정입니다.
이 조사의 주요 특징:
- 이 조사는 다양한 부문의 잠재적 수익 성장 기회를 밝히고, 이 시장에서 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 촉진요인, 시장 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채택한 경쟁 전략에 대한 중요한 인사이트를 제공합니다.
- 이 조사는 다음과 같은 매개 변수를 기반으로 세계 뇌실외배액 시장의 주요 기업 프로파일을 작성했습니다. 구체적으로는 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략 등입니다.
- 이 보고서의 내용을 통해 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있을 것입니다.
- 이 세계 뇌실외배액 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 뇌실외배액 시장을 분석하는 데 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 가정
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 뇌실외배액 시장 : 용도별, 2021-2033년
제5장 세계의 뇌실외배액 시장 : 환자 유형별, 2021-2033년
제6장 세계의 뇌실외배액 시장 : 최종사용자별, 2021-2033년
제7장 세계의 뇌실외배액 시장 : 지역별, 2021-2033년
제8장 경쟁 구도
제9장 섹션
KSM 26.06.17Global External Ventricular Drain Market is estimated to be valued at USD 7.31 Bn in 2026 and is expected to reach USD 11 Bn by 2033, growing at a compound annual growth rate (CAGR) of 6.0% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 7.31 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 6.00% | 2033 Value Projection: | USD 11 Bn |
An external ventricular drain (EVD) is a soft catheter that is inserted via a burr hole into the anterior horn of the lateral ventricle and connected to a closed sterile system to allow for temporary drainage of cerebrospinal fluid (CSF) and/or monitoring of intracranial pressure. Indications for external ventricular drainage are: to relieve raised intracranial pressure, to divert infected CSF, to divert bloodstained CSF following neurosurgery/haemorrhage, to divert the flow of CSF, and to monitor intracranial pressure. External drainage and monitoring is the standard of care for temporarily controlling intracranial pressure by draining cerebrospinal fluid externally from the body. External drainage and monitoring is the temporary drainage of cerebrospinal fluid (CSF) from the lateral ventricles of the brain, or the lumbar space of the spine, into an external collection bag. An external ventricular drainage (EVD) system drains CSF by using a combination of gravity and intercerebral pressure. The drainage rate depends on the height at which the EVD system is placed relative to the patient's anatomy.
Market Dynamics:
Increasing research and development (R&D) activities is expected to drive the growth of the global external ventricular drain market over the forecast period. For instance, in June 2025, Karolinska University Hospital, a hospital based in Sweden, initiated a clinical trial titled "Novel Diagnostic Methods to Identify External Ventricular Drain Associated Infections". This study will evaluate three novel diagnostic methods for rapid direct bacterial detection in CSF, in order to assess, if these can be used to guide antibiotic treatment in neurocritically ill patients, as compared to CSF bacterial cultures. The study is expected to get completed by December 31, 2026.
Key Features of the Study:
- It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global external ventricular drain market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Spiegelberg GmbH & Co. KG, Medtronic, Sophysa, Neuromedex GmbH, Integra LifeSciences, Moller Medical GmbH, B. Braun SE and Fuji Systems
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global external ventricular drain market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global external ventricular drain market
Detailed Segmentation:
- Global External Ventricular Drain Market, By Application (Revenue, USD Bn, 2021 - 2033)
- Traumatic Brain Injury
- Subarachnoid Hemorrhage
- Intracerebral Hemorrhage
- Other (Non-traumatic Hydrocephalus Condition)
- Global External Ventricular Drain Market, By Patient Type (Revenue, USD Bn, 2021 - 2033)
- Pediatric
- Adult
- Global External Ventricular Drain Market, By End User (Revenue, USD Bn, 2021 - 2033)
- Hospitals
- Clinics
- Ambulatory Surgery Centers
- Others
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Top Companies in the Global External Ventricular Drain Market:
- Spiegelberg GmbH & Co. KG
- Medtronic
- Sophysa
- Neuromedex GmbH
- Integra LifeSciences
- Moller Medical GmbH
- B. Braun SE
- Fuji Systems
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Application
- Market Snippet, By Patient Type
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Increasing prevalence of traumatic injuries
- Risk of post-surgery infections
- Emerging markets in the Asia Pacific region
- Key Highlights
- Recent Trends
- PEST Analysis
- Recent Product Lauches/Approvals
- Mergers, Acquisitions, and Collaborations
4. Global External Ventricular Drain Market, By Application, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Traumatic Brain Injury
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Subarachnoid Hemorrhage
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Intracerebral Hemorrhage
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Other (Non-traumatic Hydrocephalus Condition)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
5. Global External Ventricular Drain Market, By Patient Type, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Pediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Adult
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
6. Global External Ventricular Drain Market, By End User, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Hospice Care Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
7. Global External Ventricular Drain Market, By Region, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2021 - 2033
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033,(US$ Bn)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- Company Profile
- Spiegelberg GmbH & Co. KG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Medtronic
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Sophysa
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Neuromedex GmbH
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Integra LifeSciences
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Moller Medical GmbH
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Braun SE
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Fuji Systems
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Spiegelberg GmbH & Co. KG
- Analyst Views
9. Section
- References
- Research Methodology
- About us
